Digipath Inc DIGP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DIGP is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.00–0.07
- Bid/Ask
- $0.03 / $0.03
- Market Cap
- $2.65 Mil
- Volume/Avg
- 27,881 / 76,439
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
DigiPath Inc is engaged in providing pharmaceutical-grade analysis and testing cannabis education and training and brings unbiased cannabis news coverage to the cannabis industry. It screens medicinal cannabis for potentially harmful contaminants, including solvents, pesticides, mold and yeast, heavy metals such as mercury, arsenic, cadmium, and others. It also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 17
- Website
- https://www.digipath.com
Valuation
|
Metric
|
DIGP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
DIGP
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.28 |
Interest Coverage | −0.66 |
Quick Ratio
DIGP
Profitability
|
Metric
|
DIGP
|
|---|---|
Return on Assets (Normalized) | −50.00% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −122.90% |
Return on Assets
DIGP
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Nphkfcpzx | Lzs | $209.3 Bil | |
DHR
| Danaher Corp | Zxszrxfrl | Zhyll | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Ghyyqzf | Scmnxq | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Wqnskhgwv | Rthlfh | $41.0 Bil | |
A
| Agilent Technologies Inc | Crkdvbqlr | Qdt | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Cshkkkfmc | Ctsjkv | $26.4 Bil | |
ICLR
| Icon PLC | Fmtrfcpzv | Wqzcjf | $25.2 Bil | |
ILMN
| Illumina Inc | Xhgcckpd | Lycpln | $19.6 Bil | |
WAT
| Waters Corp | Gvrndjdcn | Hdx | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Vpjlsxsww | Yjdkyn | $17.5 Bil |